% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Porubsky:169377,
author = {S. Porubsky and M. Nientiedt and M. C. Kriegmair and J. H.
Siemoneit and R. Sandhoff$^*$ and R. Jennemann$^*$ and H.
Borgmann and T. Gaiser and C.-A. Weis and P. Erben and T.
Hielscher$^*$ and Z. V. Popovic},
title = {{T}he prognostic value of
galactosylceramide-sulfotransferase ({G}al3{ST}1) in human
renal cell carcinoma.},
journal = {Scientific reports},
volume = {11},
number = {1},
issn = {2045-2322},
address = {[London]},
publisher = {Macmillan Publishers Limited, part of Springer Nature},
reportid = {DKFZ-2021-01456},
pages = {10926},
year = {2021},
abstract = {Renal cell carcinoma (RCC) is the deadliest primary
genitourinary malignancy typically associated with
asymptomatic initial presentation and poorly predictable
survival. Next to established risk factors, tumor
microenvironment may alter metastatic capacity and immune
landscape. Due to their high concentrations,
sulfoglycolipids (sulfatides) were among the first
well-described antigens in RCC that are associated with
worse prognosis. As sulfatide detection in routine
diagnostics is not possible, we aimed to test the prognostic
value of its protein counterpart, sulfatide-producing enzyme
Gal3ST1. We performed retrospective long-term follow up
analysis of Gal3ST1 expression as prognostic risk factor in
a representative RCC patient cohort. We observed
differentially regulated Gal3ST1 expression in all RCC
types, being significantly more associated with clear cell
RCC than to chromophobe RCC (p = 0.001). Surprisingly, in
contrast to published observations from in vitro models, we
could not confirm an association between Gal3ST1 expression
and a malignant clinical behaviour of the RCC. In our
cohort, Gal3ST1 did not significantly influence
progression-free survival (Hazard Ratio (HR): 1.7 $95\%$ CI
(0.6-4.9), p = 0.327). Particularly after adjusting for
histology, T-stage, N-status and M-status at baseline, we
observed no independent prognostic effect (HR = 1.0 $95\%$
CI (0.3-3.3), p = 0.96). The analysis of Gal3ST1 mRNA
expression in a TCGA dataset supported the results of our
cohort. Thus, Gal3ST1 might help to differentiate between
chromophobe RCC and other frequent RCC entities but-despite
previously published data from cell culture models-does not
qualify as a prognostic marker for RCC. Further
investigation of regulatory mechanisms of sulfatide
metabolism in human RCC microenvironment is necessary to
understand the role of this quantitatively prominent
glycosphingolipid in RCC progression.},
cin = {C060 / A411},
ddc = {600},
cid = {I:(DE-He78)C060-20160331 / I:(DE-He78)A411-20160331},
pnm = {313 - Krebsrisikofaktoren und Prävention (POF4-313)},
pid = {G:(DE-HGF)POF4-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:34035403},
pmc = {pmc:PMC8149814},
doi = {10.1038/s41598-021-90381-6},
url = {https://inrepo02.dkfz.de/record/169377},
}